Isolation and characterization of RNA aptamers specific for the hepatitis C virus nonstructural protein 3 protease
Open Access
- 1 June 2000
- journal article
- research article
- Published by Wiley in European Journal of Biochemistry
- Vol. 267 (12) , 3685-3694
- https://doi.org/10.1046/j.1432-1327.2000.01400.x
Abstract
Nonstructural protein 3 (NS3) from hepatitis C virus (HCV) is a serine protease that provides an essential function in maturation of the virus by cleaving the nonstructural regions of the viral polyprotein. The goal of this work was to isolate RNA aptamers that bind specifically to the NS3 protease active site in the truncated polypeptide ΔNS3. RNA aptamers were selected in vitro by systematic evolution of ligands by exponential enrichment (SELEX). The RNA pool for SELEX had a 30‐nucleotide randomized core region. After nine selection cycles, a pool of ΔNS3‐specific RNA aptamers were obtained. This RNA pool included 45 clones that divided into three main classes (G9‐I, II and III). These classes include the conserved sequence GA(A/U)UGGGAC. These aptamers bind to ΔNS3 with a binding constant of about 10 nm and inhibit approximately 90% of the protease activity of ΔNS3 and MBP‐NS3 (full‐length of NS3 fused with maltose binding protein). In addition, these aptamers inhibited approximately 70% of the MBP‐NS3 protease activity in the presence of the NS4A peptide P41. G9‐I aptamer appeared to be a noncompetitive inhibitor for ΔNS3 with a Ki ≈ 100 nm in the presence of P41. These results suggest that the pool of selected aptamers have potential as anti‐HCV compounds. Mutational analysis of the G9‐I aptamer demonstrated that the sequences required for protease inhibition are in stem I, stem III and loop III of the aptamer. These regions include the conserved sequence GA(A/U)UGGGAC.Keywords
This publication has 49 references indexed in Scilit:
- Design of Selective Eglin Inhibitors of HCV NS3 ProteinaseBiochemistry, 1998
- Potent Peptide Inhibitors of Human Hepatitis C Virus NS3 Protease Are Obtained by Optimizing the Cleavage ProductsBiochemistry, 1998
- Isolation of RNA Aptamers Specific to the NS3 Protein of Hepatitis C Virus from a Pool of Completely Random RNAVirology, 1997
- Novel Hepatitis C Virus Protease Inhibitors: Thiazolidine DerivativesBiochemical and Biophysical Research Communications, 1997
- Expression of highly active recombinant NS3 protease domain of hepatitis C virus in E. coliFEBS Letters, 1997
- Hepatitis C and Hepatocellular CarcinomaSeminars in Liver Disease, 1995
- Production of Nonstructural Proteins of Hepatitis C Virus Requires a Putative Viral Protease Encoded by NS3Virology, 1994
- In vitro selection of RNA molecules that bind specific ligandsNature, 1990
- Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA PolymeraseScience, 1990
- Amplification, mutation and selection of catalytic RNAGene, 1989